menu
    • menu

    Company profile for NX Development Corp

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NX Development Corp. (NXDC) is a life sciences company based in Lexington, KY dedicated to the development of ALA HCl for tumor visualization. NXDC is a wholly-owned subsidiary of photonamic GmbH & Co. KG in Pinneberg, Germany (PHN). PHN is the licensor of GleolanTM (aminolevulinic acid HCl [ALA HCl]) to NXDC. The companies share an eight-year working relationship and are wholly-owned by SBI Holdings Inc. in Tokyo, Japan.Chan...
    NX Development Corp. (NXDC) is a life sciences company based in Lexington, KY dedicated to the development of ALA HCl for tumor visualization. NXDC is a wholly-owned subsidiary of photonamic GmbH & Co. KG in Pinneberg, Germany (PHN). PHN is the licensor of GleolanTM (aminolevulinic acid HCl [ALA HCl]) to NXDC. The companies share an eight-year working relationship and are wholly-owned by SBI Holdings Inc. in Tokyo, Japan.Changing the face of cancer one patient at a time by enhancing the visualization and precision of cancer surgery, giving patients a chance at a longer and better quality of life.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NX Development CorpUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    870 Corporate Drive, Suite 403, Lexington, Ky 40503
    Telephone
    Telephone
    1-833-453-6526
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nxdevcorp.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nxdevcorp/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/nxdevcorp

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AACR Annual meeting

    AACR Annual meeting

    Not Confirmed

    envelop Contact Supplier

    AACR Annual meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NX Development Corp Seeks FDA Approval For MEN-301 Study
    NX Development Corp Seeks FDA Approval For MEN-301 Study

    06 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-06/nx-development-corp-submits-supplemental-new-drug-application-to-fda-for-men-301-study

    PHARMIWEB
    06 Apr 2026
    Share Share
    Gleolan(R) sales and marketing rights return to NX Development
    Gleolan(R) sales and marketing rights return to NX Development

    24 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/sales-and-marketing-rights-of-gleolan(r)-(aminolevulinic-acid-hcl)-re-1019241

    ACCESSWIRE
    24 Apr 2025
    Share Share
    NX Enrolls First Patient in OVA-302 Study After FDA Orphan Designation
    NX Enrolls First Patient in OVA-302 Study After FDA Orphan Designation

    21 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=879386&lang=en

    ACCESSWIRE
    21 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search